By Sheri Kasprzak
New York, Aug. 25 - Regeneration Technologies, Inc. said it has received definitive agreements for its $23.94 million private placement.
The company will issue 2.8 million shares at $8.55 each to accredited investors.
Proceeds from the deal will be used for working capital.
Alachua, Fla.-based Regeneration makes allograft and xenograft tissue into shaped implants for orthopedic, cardiovascular and other surgeries.
| Issuer: | Regeneration Technologies, Inc.
|
| Issue: | Stock
|
| Amount: | $23.94 million
|
| Shares: | 2.8 million
|
| Price: | $8.55
|
| Warrants: | No
|
| Announcement date: | Aug. 25
|
| Stock price: | $9.55 at close Aug. 24
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
